Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_29108 | 43 | 0.90 | Mlig455_052031 | Neo: - Age: logFC(26M/2M)=-0.764 |
Mlig455_052031 {REF} {Length: 3111} {NoTransDecoderORF} {RNA1310_19531.2} {RNA815_10097} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.409 | 1.37 | 0.56288 | 1.00000 | |
RegionR2 | 2.475 | 1.37 | 0.09900 | 0.38650 | |
RegionR3 | -0.217 | 1.37 | 0.89707 | 1.00000 | |
RegionR4 | -0.511 | 1.37 | 0.93800 | 1.00000 | |
RegionR5 | -0.191 | 1.37 | 0.88490 | 1.00000 | |
RegionR6 | 0.315 | 1.37 | 0.70369 | 1.00000 | |
RegionR7 | -0.019 | 1.37 | 0.86455 | 1.00000 | |
RegionR8 | -3.259 | 1.37 | 0.39813 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -3.888 | 1.37 | 0.56210 | 1.00000 | |
RegenerationR2 | 0.096 | 1.37 | 0.92421 | 1.00000 | |
RegenerationR3 | 0.834 | 1.37 | 0.51816 | 0.86553 | |
RegenerationR4 | 0.845 | 1.37 | 0.54741 | 0.89153 | |
RegenerationR5 | -0.15 | 1.37 | 0.88957 | 1.00000 | |
RegenerationR6 | 0.797 | 1.37 | 0.52233 | 0.82209 | |
RegenerationBL | -2.121 | 1.37 | 1.00000 | 1.00000 | |
RegenerationTP | 2.236 | 1.37 | 0.38354 | 0.81781 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_29108 | 43 | 0.9 | Mlig455_052031 | Neo: - Age: logFC(26M/2M)=-0.764 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_052031 {REF} {Length: 3111} {NoTransDecoderORF} {RNA1310_19531.2} {RNA815_10097} | |
2. | MligTC455_29109 | 90 | 1.88 | Mlig455_057258 | Neo: - Age: - |
3.466 | - | 0.745 | 0.874 | 0.879 | 0.968 | - | Mlig455_057258 {REF} {Length: 2483} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_21788} {RNA815_10097} | |
3. | MligTC455_22356 | 28 | 0.57 | Mlig455_009532 | Neo: - Age: - Region-enriched R5: 4.548/0.03532 |
GALR2 | 1.899 | - | - | 1.000 | - | 0.899 | - | Mlig455_009532 {REF} {Length: 3801} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.4]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.8, Expect=6e-06]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [Score=126, Expect=3e-31]} {RNA1310_79397} {RNA815_39017} |
4. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 1.817 | - | - | 0.856 | - | 0.961 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
5. | MligTC455_52076 | 203 | 4.23 | Mlig455_066929 | Neo: - Age: - |
NXF1 | 1.813 | - | - | 0.957 | - | - | 0.856 | Mlig455_066929 {REF} {Length: 3005} {Pfam: TAP C-terminal domain [PF03943.15, score=70.6]; Tap, RNA-binding [PF09162.12, score=66.9]} {Human: ENSG00000162231, NXF1, nuclear RNA export factor 1, [Score=186, Expect=1e-50]; ENSG00000269437, NXF2B, nuclear RNA export factor 2B, [Score=185, Expect=3e-50]; ENSG00000269405, NXF2, nuclear RNA export factor 2, [Score=185, Expect=3e-50]} {Mouse: ENSMUSG00000010097, Nxf1, nuclear RNA export factor 1, [Score=186, Expect=1e-50]} {Dmel: FBgn0003321, sbr, small bristles, [Score=134, Expect=8e-33]} {Celegans: WBGene00003834, nxf-1, Nuclear RNA export factor 1, [Score=98.6, Expect=2e-21]} {Smed: dd_Smed_v6_6082_0_1, dd_Smed_v6_6082_0_1, [Score=63.9, Expect=1e-10]} {RNA1509_6988} {RNA1310_4213} {RNA815_4098.1} |
6. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 1.807 | - | - | 0.852 | - | 0.955 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
7. | MligTC455_07554 | 24 | 0.51 | Mlig455_027995 | Neo: - Age: - |
GALR2 | 1.805 | - | - | 0.843 | - | 0.962 | - | Mlig455_027995 {REF} {Length: 2582} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=49.3, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=59.3, Expect=4e-09]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=184, Expect=9e-53]} |
8. | MligTC455_35769 | 90 | 1.87 | Mlig455_034140, Mlig455_050376, Mlig455_062180 | Neo: - |
1.794 | - | - | 0.950 | - | 0.844 | - | Mlig455_034140 {REF} {Length: 1714} {RNA1509_25690} {RNA1310_57234} {RNA815_17883} Mlig455_050376 {REF} {Length: 2093} {TRANSSPLICED} {RNA1509_54944} {RNA1310_23258} {RNA815_47172} Mlig455_062180 {REF} {Length: 90} {NoTransDecoderORF} {RNA1509_25690} {RNA1310_65891} {RNA815_17883} |
|
9. | MligTC455_19701 | 63 | 1.32 | Mlig455_039776 | Neo: - Age: - Region-enriched R4: 4.356/0.04826 |
1.786 | - | - | - | - | 0.814 | 0.972 | Mlig455_039776 {REF} {Length: 884} {NoTransDecoderORF} {RNA1310_39282} {RNA815_40382} | |
10. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
1.733 | - | - | 0.959 | - | 0.774 | - | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
11. | MligTC455_25654 | 389 | 8.11 | Mlig455_000129, Mlig455_027212, Mlig455_028212, Mlig455_028213, Mlig455_028214, Mlig455_039873, Mlig455_064984 | Neo: - Age: - Region-enriched R4: 2.312/0.04499 |
1.716 | - | - | 0.760 | - | 0.956 | - | Mlig455_000129 {REF} {Length: 1124} {Celegans: WBGene00007723, C25F9.2, [Score=62.0, Expect=8e-11]} {RNA1310_7131} {RNA815_8935} Mlig455_027212 {REF} {Length: 2742} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=139.5]} {Celegans: WBGene00007723, C25F9.2, [Score=313, Expect=4e-91]} {RNA1310_7131} {RNA815_8935} Mlig455_028212 {REF} {Length: 638} {NoTransDecoderORF} {RNA1509_31372} {RNA1310_7131} {RNA815_8935} Mlig455_028213 {REF} {Length: 1119} {Celegans: WBGene00007723, C25F9.2, [Score=78.2, Expect=1e-16]} {RNA1310_7131} {RNA815_8935} Mlig455_028214 {REF} {Length: 1116} {Celegans: WBGene00007723, C25F9.2, [Score=78.2, Expect=1e-16]} {RNA1310_7131} {RNA815_8935} Mlig455_039873 {REF} {Length: 3987} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=89.9]} {Celegans: WBGene00007723, C25F9.2, [Score=291, Expect=4e-82]} {RNA1310_7131} {RNA815_8935} Mlig455_064984 {REF} {Length: 2969} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=136.0]} {Celegans: WBGene00007723, C25F9.2, [RH, Score=373, Expect=3e-111]} {RNA1310_7131} {RNA815_8935} |
|
12. | MligTC455_39719 | 44 | 0.92 | Mlig455_063602 | Neo: - Age: - |
MPDZ | 1.711 | - | - | 0.950 | - | 0.761 | - | Mlig455_063602 {REF} {Length: 2307} {Pfam: PDZ domain [PF00595.26, score=187.6]; PDZ domain [PF17820.3, score=85.4]; PDZ domain [PF13180.8, score=85.1]} {Human: ENSG00000107186, MPDZ, multiple PDZ domain crumbs cell polarity complex component, [Score=244, Expect=9e-70]} {Mouse: ENSMUSG00000028402, Mpdz, multiple PDZ domain protein, [Score=237, Expect=7e-67]} {Dmel: FBgn0263289, scrib, scribbled, [Score=88.6, Expect=6e-18]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=137, Expect=7e-35]} {Smed: dd_Smed_v6_4520_0_1, dd_Smed_v6_4520_0_1, [Score=147, Expect=2e-37]} {RNA1310_8275.3} {RNA815_16615} |
13. | MligTC455_35837 | 20 | 0.43 | Mlig455_050733, Mlig455_050742 | Neo: - Age: - |
SLC6A2 | 1.707 | - | - | - | - | 0.950 | 0.757 | Mlig455_050733 {REF} {Length: 2445} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=693.3]} {Human: ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [RH, Score=606, Expect=0.0]; ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [RH, Score=582, Expect=0.0]; ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [RH, Score=582, Expect=0.0]} {Mouse: ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [RH, Score=607, Expect=0.0]; ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [RH, Score=592, Expect=0.0]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [RH, Score=699, Expect=0.0]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=588, Expect=0.0]} {Smed: dd_Smed_v6_17986_0_1, dd_Smed_v6_17986_0_1, [Score=732, Expect=0.0]} {RNA1509_10666} {RNA1310_45533} {RNA815_36799} Mlig455_050742 {REF} {Length: 6785} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=706.3]} {Human: ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [RH, Score=614, Expect=0.0]; ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [RH, Score=591, Expect=0.0]; ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [RH, Score=591, Expect=0.0]} {Mouse: ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [RH, Score=612, Expect=0.0]; ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [RH, Score=601, Expect=0.0]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [RH, Score=711, Expect=0.0]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [RH, Score=597, Expect=0.0]} {Smed: dd_Smed_v6_17986_0_1, dd_Smed_v6_17986_0_1, [RH, Score=751, Expect=0.0]} {RNA1509_10666} {RNA1310_45533} {RNA815_36799} |
14. | MligTC455_40596 | 131 | 2.74 | Mlig455_029755, Mlig455_029759, Mlig455_029851 | Neo: - Age: - |
PCDH17, PCDH9 | 1.701 | - | - | 0.736 | - | 0.965 | - | Mlig455_029755 {REF} {Length: 3844} {Pfam: Cadherin domain [PF00028.19, score=281.1]; Cadherin-like [PF08266.14, score=32.1]; Cadherin-like [PF16184.7, score=23.9]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=239, Expect=6e-64]; ENSG00000169851, PCDH7, protocadherin 7, [Score=228, Expect=1e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=236, Expect=3e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=227, Expect=1e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=227, Expect=4e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_2654_0_1, dd_Smed_v6_2654_0_1, [Score=251, Expect=4e-69]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029759 {REF} {Length: 2237} {Pfam: Cadherin domain [PF00028.19, score=169.5]; Cadherin-like [PF16184.7, score=19.9]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [Score=190, Expect=5e-51]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=181, Expect=2e-48]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [Score=189, Expect=1e-50]; ENSMUSG00000047307, Pcdhb13, protocadherin beta 13, [Score=187, Expect=1e-50]; ENSMUSG00000045689, Pcdhb4, protocadherin beta 4, [Score=185, Expect=9e-50]; ENSMUSG00000063687, Pcdhb5, protocadherin beta 5, [Score=184, Expect=2e-49]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=182, Expect=2e-48]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=180, Expect=4e-48]} {Dmel: FBgn0284247, ds, dachsous, [Score=158, Expect=3e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=126, Expect=5e-30]} {Smed: dd_Smed_v6_15376_0_1, dd_Smed_v6_15376_0_1, [Score=192, Expect=3e-52]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029851 {REF} {Length: 4327} {Pfam: Cadherin domain [PF00028.19, score=280.6]; Cadherin-like [PF08266.14, score=32.2]; Cadherin-like [PF16184.7, score=23.7]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=237, Expect=2e-63]; ENSG00000169851, PCDH7, protocadherin 7, [Score=226, Expect=3e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=225, Expect=5e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=226, Expect=7e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=4e-42]} {Smed: dd_Smed_v6_11605_0_1, dd_Smed_v6_11605_0_1, [Score=250, Expect=8e-69]} {RNA1509_47646} {RNA1310_26844, RNA1509_47646} {RNA1509_47646, RNA815_60336} |
15. | MligTC455_25820 | 32 | 0.67 | Mlig455_061208 | Neo: - Age: - |
1.7 | - | - | 0.964 | - | 0.736 | - | Mlig455_061208 {REF} {Length: 1262} {Celegans: WBGene00018026, F35A5.4, [Score=48.1, Expect=1e-06]} {RNA1310_123558} | |
16. | MligTC455_51760 | 18 | 0.38 | Mlig455_051796 | Neo: - Age: - |
CNBD2 | 1.685 | - | - | 0.971 | - | 0.714 | - | Mlig455_051796 {REF} {Length: 2614} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=74.7]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=67.4, Expect=2e-11]; ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=64.3, Expect=4e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=64.7, Expect=2e-10]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=63.9, Expect=2e-10]} {Dmel: FBgn0259243, Pka-R1, Protein kinase, cAMP-dependent, regulatory subunit type 1, [Score=57.4, Expect=1e-08]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=174, Expect=1e-46]} {RNA1310_33768} {RNA815_47620} |
17. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
18. | MligTC455_10413 | 12 | 0.24 | Mlig455_053242, Mlig455_066367 | Neo: - Age: - |
LHFPL6 | 0.984 | - | - | 0.984 | - | - | - | Mlig455_053242 {REF} {Length: 1343} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1310_36894} {RNA815_56428} Mlig455_066367 {REF} {Length: 1706} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1509_28410} {RNA1310_83173.1} {RNA815_56428} |
19. | MligTC455_42514 | 28 | 0.59 | Mlig455_027746 | Neo: - Age: Up-Down-Down |
KCNC2 | 0.984 | - | - | 0.984 | - | - | - | Mlig455_027746 {REF} {Length: 2596} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.8]; Ion channel [PF07885.18, score=37.1]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=2e-86]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=279, Expect=3e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=270, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=3e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=270, Expect=2e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=280, Expect=7e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=3e-94]} {Smed: dd_Smed_v6_13250_0_1, dd_Smed_v6_13250_0_1, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
20. | MligTC455_21228 | 91 | 1.89 | Mlig455_010973 | Neo: - Age: - |
NOS1AP | 0.98 | - | - | 0.980 | - | - | - | Mlig455_010973 {REF} {Length: 3372} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=84.5]} {Human: ENSG00000198929, NOS1AP, nitric oxide synthase 1 adaptor protein, [RH, Score=210, Expect=2e-61]} {Mouse: ENSMUSG00000038473, Nos1ap, nitric oxide synthase 1 (neuronal) adaptor protein, [RH, Score=209, Expect=5e-61]} {Dmel: FBgn0261555, CG42673, [RH, Score=209, Expect=2e-59]} {Celegans: WBGene00001116, dyc-1, Dystrophin-like protein 1, [Score=205, Expect=2e-57]} {Smed: dd_Smed_v6_13377_0_1, dd_Smed_v6_13377_0_1, [Score=218, Expect=5e-64]} {RNA1509_56125} {RNA1310_16551, RNA1509_56125} {RNA1509_56125, RNA815_36051} |
21. | MligTC455_46719 | 52 | 1.07 | Mlig455_062168, Mlig455_062198 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_062168 {REF} {Length: 3050} {RNA1310_69620} Mlig455_062198 {REF} {Length: 3050} {RNA1310_69620} |
|
22. | MligTC455_37351 | 33 | 0.68 | Mlig455_061197 | Neo: - Age: - Regeneration-upregulated R2: 6.835 Regeneration-enriched R2: 6.835 |
0.977 | - | - | - | - | 0.977 | - | Mlig455_061197 {REF} {Length: 2072} {Pfam: RNase H [PF00075.26, score=59.1]} {RNA1509_53488} {RNA1310_40766} | |
23. | MligTC455_19044 | 429 | 8.94 | Mlig455_000260, Mlig455_058541 | Neo: - Age: - Region-enriched R5: 2.010/0.02766 |
FAN1 | 0.976 | - | - | 0.976 | - | - | - | Mlig455_000260 {REF} {Length: 3396} {TRANSSPLICED} {Pfam: VRR-NUC domain [PF08774.13, score=64.9]} {Human: ENSG00000276787, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=169, Expect=1e-42]; ENSG00000198690, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=169, Expect=1e-42]} {Mouse: ENSMUSG00000033458, Fan1, FANCD2/FANCI-associated nuclease 1, [RH, Score=172, Expect=6e-44]} {Celegans: WBGene00015310, fan-1, Fanconi-associated nuclease 1 homolog, [RH, Score=161, Expect=8e-41]} {Smed: dd_Smed_v6_10078_0_1, dd_Smed_v6_10078_0_1, [RH, Score=116, Expect=9e-27]} {RNA1509_31937} {RNA1310_7182, RNA1509_31937} {RNA1509_31937, RNA815_30391} Mlig455_058541 {REF} {Length: 3398} {TRANSSPLICED} {Pfam: VRR-NUC domain [PF08774.13, score=65.0]} {Human: ENSG00000198690, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=173, Expect=8e-44]; ENSG00000276787, FAN1, FANCD2 and FANCI associated nuclease 1, [RH, Score=173, Expect=8e-44]} {Mouse: ENSMUSG00000033458, Fan1, FANCD2/FANCI-associated nuclease 1, [RH, Score=175, Expect=1e-44]} {Celegans: WBGene00015310, fan-1, Fanconi-associated nuclease 1 homolog, [RH, Score=161, Expect=1e-40]} {Smed: dd_Smed_v6_10078_0_1, dd_Smed_v6_10078_0_1, [RH, Score=112, Expect=2e-25]} {RNA1509_31937, RNA1509_37727, RNA1509_40132} {RNA1310_7182, RNA1509_37727, RNA1509_40132} {RNA1509_37727, RNA1509_40132, RNA815_30391} |
24. | MligTC455_37325 | 21 | 0.45 | Mlig455_053385 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_053385 {REF} {Length: 347} {NoTransDecoderORF} {RNA1509_46225} {RNA1310_43662} | |
25. | MligTC455_34815 | 30 | 0.63 | Mlig455_020979 | Neo: - Age: - |
0.973 | - | - | 0.973 | - | - | - | Mlig455_020979 {REF} {Length: 1394} {RNA1310_37266} | |
26. | MligTC455_28509 | 143 | 2.97 | Mlig455_050246 | Neo: - Age: logFC(26M/2M)=-0.382 |
WDR49 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_050246 {REF} {Length: 5989} {Pfam: WD domain, G-beta repeat [PF00400.34, score=43.1]; EF-hand domain pair [PF13499.8, score=28.7]; Nup133 N terminal like [PF08801.13, score=22.4]; EF-hand domain pair [PF13833.8, score=21.5]; EF hand [PF00036.34, score=20.0]} {Human: ENSG00000174776, WDR49, WD repeat domain 49, [Score=329, Expect=3e-96]} {Mouse: ENSMUSG00000044083, Efcab8, EF-hand calcium binding domain 8, [RH, Score=258, Expect=2e-70]} {Dmel: FBgn0267449, WDY, WD40 Y, [RH, Score=197, Expect=3e-51]} {Celegans: WBGene00010572, wdr-5.2, WD repeat-containing protein wdr-5.2, [Score=53.9, Expect=4e-07]} {Smed: dd_Smed_v6_5437_0_2, dd_Smed_v6_5437_0_2, [Score=302, Expect=2e-86]} {RNA1509_11289, RNA1509_17402, RNA1509_54041} {RNA1310_2314.2, RNA1509_11289, RNA1509_17402, RNA1509_54041} {RNA1509_11289, RNA1509_17402, RNA1509_54041, RNA815_2581} |
27. | MligTC455_27532 | 14 | 0.3 | Mlig455_050096 | Neo: - Age: - |
ITPKA | 0.971 | - | - | - | - | 0.971 | - | Mlig455_050096 {REF} {Length: 2853} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=89.5]} {Human: ENSG00000137825, ITPKA, inositol-trisphosphate 3-kinase A, [Score=206, Expect=4e-60]; ENSG00000143772, ITPKB, inositol-trisphosphate 3-kinase B, [Score=198, Expect=2e-54]} {Mouse: ENSMUSG00000027296, Itpka, inositol 1,4,5-trisphosphate 3-kinase A, [Score=207, Expect=6e-61]; ENSMUSG00000003752, Itpkc, inositol 1,4,5-trisphosphate 3-kinase C, [Score=197, Expect=2e-55]; ENSMUSG00000038855, Itpkb, inositol 1,4,5-trisphosphate 3-kinase B, [Score=197, Expect=4e-54]} {Dmel: FBgn0032147, IP3K1, Inositol 1,4,5-triphosphate kinase 1, [Score=180, Expect=4e-52]} {Celegans: WBGene00002979, lfe-2, Inositol-trisphosphate 3-kinase homolog, [Score=207, Expect=8e-62]} {Smed: dd_Smed_v6_3687_0_2, dd_Smed_v6_3687_0_2, [Score=182, Expect=6e-51]} {RNA1509_15208} {RNA1310_45410.1} {RNA815_8803} |
28. | MligTC455_10771 | 22 | 0.45 | Mlig455_020287 | Neo: - Age: - |
LCK | 0.97 | - | - | - | - | 0.970 | - | Mlig455_020287 {REF} {Length: 6454} {Pfam: Variant SH3 domain [PF14604.8, score=39.7]; SH3 domain [PF00018.30, score=38.4]; SH2 domain [PF00017.26, score=27.6]; Variant SH3 domain [PF07653.19, score=20.7]} {Human: ENSG00000182866, LCK, LCK proto-oncogene, Src family tyrosine kinase, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000000409, Lck, lymphocyte protein tyrosine kinase, [Score=95.1, Expect=2e-20]} {Dmel: FBgn0262733, Src64B, Src oncogene at 64B, [Score=81.6, Expect=3e-16]} {Smed: dd_Smed_v6_3147_0_1, dd_Smed_v6_3147_0_1, [Score=103, Expect=1e-23]} {RNA1509_5045} {RNA1310_667.1} {RNA815_350} |
29. | MligTC455_20111 | 14 | 0.29 | Mlig455_028941 | Neo: - Age: - |
IGSF9 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_028941 {REF} {Length: 3748} {Pfam: Immunoglobulin domain [PF13927.8, score=128.9]; Immunoglobulin I-set domain [PF07679.18, score=93.2]; Immunoglobulin domain [PF13895.8, score=81.2]; Immunoglobulin domain [PF00047.27, score=74.0]; Immunoglobulin V-set domain [PF07686.19, score=70.7]; Fibronectin type III domain [PF00041.23, score=38.4]; Izumo-like Immunoglobulin domain [PF16706.7, score=26.6]; Immunoglobulin domain [PF18452.3, score=21.2]} {Human: ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=149, Expect=1e-35]} {Mouse: ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=149, Expect=6e-36]; ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=145, Expect=8e-35]} {Dmel: FBgn0028482, bdl, borderless, [Score=125, Expect=6e-29]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=137, Expect=6e-33]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=140, Expect=9e-34]} {RNA1310_20896} {RNA815_28649} |
30. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
31. | MligTC455_02244 | 25 | 0.53 | Mlig455_026007, Mlig455_070432 | Neo: - Age: - |
0.966 | - | - | 0.966 | - | - | - | Mlig455_026007 {REF} {Length: 604} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=91.3, Expect=3e-24]} {RNA1310_143494} Mlig455_070432 {REF} {Length: 1561} {Dmel: FBgn0050419, CG30419, [RH, Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [RH, Score=112, Expect=2e-32]} {RNA1310_143494} |
|
32. | MligTC455_29543 | 94 | 1.96 | Mlig455_066835 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.991/0.02759 |
PGBD4 | 0.966 | - | - | 0.966 | - | - | - | Mlig455_066835 {REF} {Length: 7088} {Pfam: Transposase IS4 [PF13843.8, score=213.7]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [RH, Score=206, Expect=4e-59]} {Mouse: ENSMUSG00000050751, Pgbd5, piggyBac transposable element derived 5, [RH, Score=74.3, Expect=1e-13]} {Dmel: FBgn0037633, CG9839, [RH, Score=96.3, Expect=7e-21]} {Smed: dd_Smed_v6_48522_0_1, dd_Smed_v6_48522_0_1, [RH, Score=116, Expect=1e-29]} {RNA1509_18157} {RNA1310_616.1} {RNA815_9301.1} |
33. | MligTC455_14623 | 7 | 0.14 | Mlig455_007358 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_007358 {REF} {Length: 1844} {RNA1509_11595} {RNA1310_15289} {RNA815_22582} | |
34. | MligTC455_22633 | 139 | 2.89 | Mlig455_009988 | Neo: Germline Age: Down-Down-Up Region-specific R4: 5.415 Region-enriched R4: 4.245/0.00064 |
0.965 | - | - | - | 0.965 | - | - | Mlig455_009988 {REF} {Length: 1164} {RNA1509_107, RNA1509_566} {RNA1310_16855, RNA1509_566} {RNA1509_566, RNA815_6242.1} | |
35. | MligTC455_44516 | 146 | 3.04 | Mlig455_000275, Mlig455_021203, Mlig455_035729, Mlig455_058354 | Neo: - Age: - |
ASB3, MIB1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_000275 {REF} {Length: 1776} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=86.3]; Ankyrin repeat [PF00023.32, score=56.5]; Ankyrin repeats (many copies) [PF13637.8, score=55.7]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=48.2]; Ankyrin repeats (many copies) [PF13857.8, score=39.6]; Ankyrin repeat [PF13606.8, score=32.2]; Prokaryotic RING finger family 4 [PF14447.8, score=18.4]} {Human: ENSG00000115239, ASB3, ankyrin repeat and SOCS box containing 3, [Score=60.8, Expect=1e-09]; ENSG00000270898, GPR75-ASB3, GPR75-ASB3 readthrough, [Score=60.5, Expect=1e-09]; ENSG00000170209, ANKK1, ankyrin repeat and kinase domain containing 1, [Score=60.5, Expect=2e-09]; ENSG00000029534, ANK1, ankyrin 1, [Score=60.1, Expect=2e-09]} {Mouse: ENSMUSG00000032257, Ankk1, ankyrin repeat and kinase domain containing 1, [Score=57.8, Expect=8e-09]; ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=57.8, Expect=7e-09]; ENSMUSG00000020305, Asb3, ankyrin repeat and SOCS box-containing 3, [Score=56.6, Expect=1e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=56.6, Expect=1e-08]; ENSMUSG00000024294, Mib1, mindbomb E3 ubiquitin protein ligase 1, [Score=56.2, Expect=2e-08]; ENSMUSG00000036333, Kidins220, kinase D-interacting substrate 220, [Score=55.8, Expect=4e-08]} {Dmel: FBgn0086442, mib2, mind bomb 2, [Score=70.1, Expect=5e-13]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=54.7, Expect=5e-08]} {Smed: dd_Smed_v6_1704_0_1, dd_Smed_v6_1704_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_17433.1} {RNA815_7006.1} Mlig455_021203 {REF} {Length: 1779} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=86.2]; Ankyrin repeat [PF00023.32, score=56.2]; Ankyrin repeats (many copies) [PF13637.8, score=51.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=49.3]; Ankyrin repeats (many copies) [PF13857.8, score=41.1]; Ankyrin repeat [PF13606.8, score=32.6]; Prokaryotic RING finger family 4 [PF14447.8, score=18.8]} {Human: ENSG00000101752, MIB1, mindbomb E3 ubiquitin protein ligase 1, [Score=63.9, Expect=1e-10]; ENSG00000115239, ASB3, ankyrin repeat and SOCS box containing 3, [Score=62.8, Expect=2e-10]; ENSG00000270898, GPR75-ASB3, GPR75-ASB3 readthrough, [Score=62.4, Expect=3e-10]} {Mouse: ENSMUSG00000024294, Mib1, mindbomb E3 ubiquitin protein ligase 1, [Score=64.3, Expect=5e-11]} {Dmel: FBgn0086442, mib2, mind bomb 2, [Score=71.2, Expect=2e-13]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=53.5, Expect=9e-08]} {Smed: dd_Smed_v6_1704_0_1, dd_Smed_v6_1704_0_1, [Score=84.0, Expect=9e-18]} {RNA1310_17433.1} {RNA815_7006.1} Mlig455_035729 {REF} {Length: 1776} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=87.3]; Ankyrin repeats (many copies) [PF13637.8, score=57.2]; Ankyrin repeat [PF00023.32, score=56.2]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=49.7]; Ankyrin repeats (many copies) [PF13857.8, score=41.2]; Ankyrin repeat [PF13606.8, score=34.0]; Prokaryotic RING finger family 4 [PF14447.8, score=18.4]} {Human: ENSG00000115239, ASB3, ankyrin repeat and SOCS box containing 3, [Score=62.8, Expect=2e-10]; ENSG00000270898, GPR75-ASB3, GPR75-ASB3 readthrough, [Score=62.4, Expect=3e-10]; ENSG00000029534, ANK1, ankyrin 1, [Score=60.5, Expect=2e-09]; ENSG00000170209, ANKK1, ankyrin repeat and kinase domain containing 1, [Score=60.1, Expect=2e-09]} {Mouse: ENSMUSG00000020305, Asb3, ankyrin repeat and SOCS box-containing 3, [Score=58.5, Expect=3e-09]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=58.5, Expect=3e-09]; ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=57.8, Expect=7e-09]; ENSMUSG00000032257, Ankk1, ankyrin repeat and kinase domain containing 1, [Score=57.4, Expect=9e-09]; ENSMUSG00000110333, Gm45861, predicted gene 45861, [Score=56.2, Expect=3e-08]} {Dmel: FBgn0086442, mib2, mind bomb 2, [Score=70.9, Expect=3e-13]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=53.1, Expect=1e-07]} {Smed: dd_Smed_v6_1704_0_1, dd_Smed_v6_1704_0_1, [Score=84.3, Expect=6e-18]} {RNA1310_17433.1} {RNA815_7006.1} Mlig455_058354 {REF} {Length: 1769} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=86.3]; Ankyrin repeat [PF00023.32, score=56.5]; Ankyrin repeats (many copies) [PF13637.8, score=55.7]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=48.2]; Ankyrin repeats (many copies) [PF13857.8, score=39.6]; Ankyrin repeat [PF13606.8, score=32.2]; Prokaryotic RING finger family 4 [PF14447.8, score=18.4]} {Human: ENSG00000115239, ASB3, ankyrin repeat and SOCS box containing 3, [Score=60.8, Expect=1e-09]; ENSG00000270898, GPR75-ASB3, GPR75-ASB3 readthrough, [Score=60.5, Expect=1e-09]; ENSG00000170209, ANKK1, ankyrin repeat and kinase domain containing 1, [Score=60.5, Expect=2e-09]; ENSG00000029534, ANK1, ankyrin 1, [Score=60.1, Expect=2e-09]} {Mouse: ENSMUSG00000032257, Ankk1, ankyrin repeat and kinase domain containing 1, [Score=57.8, Expect=8e-09]; ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=57.8, Expect=7e-09]; ENSMUSG00000020305, Asb3, ankyrin repeat and SOCS box-containing 3, [Score=56.6, Expect=1e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=56.6, Expect=1e-08]; ENSMUSG00000024294, Mib1, mindbomb E3 ubiquitin protein ligase 1, [Score=56.2, Expect=2e-08]; ENSMUSG00000036333, Kidins220, kinase D-interacting substrate 220, [Score=55.8, Expect=4e-08]} {Dmel: FBgn0086442, mib2, mind bomb 2, [Score=70.1, Expect=5e-13]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=54.7, Expect=5e-08]} {Smed: dd_Smed_v6_1704_0_1, dd_Smed_v6_1704_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_17433.1} {RNA815_7006.1} |
36. | MligTC455_29232 | 131 | 2.72 | Mlig455_050150 | Neo: - Age: - Regeneration-downregulated BL: -4.109 Regeneration-depleted BL: -4.109 |
PCDH9 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_050150 {REF} {Length: 3993} {Pfam: Cadherin domain [PF00028.19, score=289.2]; Cadherin-like [PF08266.14, score=40.2]; Cadherin-like [PF16184.7, score=34.6]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=302, Expect=4e-85]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [RH, Score=307, Expect=1e-86]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=7e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=330, Expect=2e-97]} {RNA1310_46914} |
37. | MligTC455_26517 | 54 | 1.13 | Mlig455_050870, Mlig455_053969 | Neo: - Age: logFC(26M/2M)=-0.514 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_050870 {REF} {Length: 3430} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=54.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.7]} {Smed: dd_Smed_v6_6819_0_2, dd_Smed_v6_6819_0_2, [Score=152, Expect=9e-42]} {RNA1509_35362} {RNA1310_8376} {RNA815_4529} Mlig455_053969 {REF} {Length: 989} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=74.2]} {Smed: dd_Smed_v6_16441_0_5, dd_Smed_v6_16441_0_5, [Score=51.6, Expect=3e-07]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
38. | MligTC455_37452 | 116 | 2.42 | Mlig455_046278 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_046278 {REF} {Length: 4416} {Pfam: Antitoxin VbhA [PF18495.3, score=20.4]} {RNA1509_26805, RNA1509_49672} {RNA1310_2903.3, RNA1509_49672} {RNA1509_49672, RNA815_6251} | |
39. | MligTC455_42756 | 115 | 2.39 | Mlig455_059859 | Neo: - Age: Up-Down-Up |
FSCN1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_059859 {REF} {Length: 2510} {Pfam: Fascin domain [PF06268.15, score=184.5]; FRG1-like domain [PF06229.14, score=76.5]; Ricin-type beta-trefoil lectin domain-like [PF14200.8, score=23.3]; Fibroblast growth factor [PF00167.20, score=21.4]; Domain of unknown function (DUF569) [PF04601.15, score=19.3]} {Human: ENSG00000075618, FSCN1, fascin actin-bundling protein 1, [Score=322, Expect=9e-105]; ENSG00000186765, FSCN2, fascin actin-bundling protein 2, retinal, [Score=308, Expect=3e-99]} {Mouse: ENSMUSG00000029581, Fscn1, fascin actin-bundling protein 1, [Score=317, Expect=1e-102]} {Dmel: FBgn0003447, sn, singed, [RH, Score=326, Expect=2e-106]} {Smed: dd_Smed_v6_996_0_1, dd_Smed_v6_996_0_1, [RH, Score=501, Expect=3e-175]} {RNA1509_53298} {RNA1310_18751.1, RNA1509_53298} {RNA1509_53298, RNA815_14175} |
40. | MligTC455_51056 | 19 | 0.4 | Mlig455_037601 | Neo: - |
PDE1C | 0.959 | - | - | 0.959 | - | - | - | Mlig455_037601 {REF} {Length: 4227} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=274.5]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=90.8]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=511, Expect=3e-172]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=516, Expect=1e-174]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=523, Expect=5e-175]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=464, Expect=1e-157]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=597, Expect=0.0]} {RNA1509_49973} {RNA1310_29187.1} {RNA815_51078.1} |
41. | MligTC455_29339 | 176 | 3.67 | Mlig455_018221, Mlig455_036131 | Neo: Irradiation Age: Up-Down-Down |
CNBP | 0.958 | - | - | 0.958 | - | - | - | Mlig455_018221 {REF} {Length: 5982} {Pfam: Zinc knuckle [PF00098.25, score=25.6]} {RNA1509_21798} {RNA1310_927.1} {RNA815_827} Mlig455_036131 {REF} {Length: 4130} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=33.3]; Aspartyl protease [PF13650.8, score=23.3]; Zinc knuckle [PF00098.25, score=23.1]} {Human: ENSG00000169714, CNBP, CCHC-type zinc finger nucleic acid binding protein, [Score=50.1, Expect=2e-06]} {Mouse: ENSMUSG00000030057, Cnbp, cellular nucleic acid binding protein, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=112, Expect=1e-25]} {RNA1509_21798} {RNA1310_927.1} {RNA815_827} |
42. | MligTC455_33423 | 15 | 0.32 | Mlig455_049077 | Neo: - Age: Up-Down-Down |
ABCC1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_049077 {REF} {Length: 4849} {Pfam: ABC transporter [PF00005.29, score=170.6]; ABC transporter transmembrane region [PF00664.25, score=46.7]; RecF/RecN/SMC N terminal domain [PF02463.21, score=44.4]; 50S ribosome-binding GTPase [PF01926.25, score=25.7]; RsgA GTPase [PF03193.18, score=21.5]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=19.3]; AAA domain [PF13401.8, score=19.0]; Protein of unknown function (DUF815) [PF05673.15, score=18.4]} {Human: ENSG00000278183, ABCC1, ATP binding cassette subfamily C member 1, [Score=430, Expect=8e-131]; ENSG00000103222, ABCC1, ATP binding cassette subfamily C member 1, [Score=430, Expect=8e-131]; ENSG00000108846, ABCC3, ATP binding cassette subfamily C member 3, [Score=421, Expect=2e-125]; ENSG00000023839, ABCC2, ATP binding cassette subfamily C member 2, [Score=419, Expect=2e-124]} {Mouse: ENSMUSG00000023088, Abcc1, ATP-binding cassette, sub-family C (CFTR/MRP), member 1, [Score=431, Expect=4e-129]; ENSMUSG00000020865, Abcc3, ATP-binding cassette, sub-family C (CFTR/MRP), member 3, [Score=427, Expect=5e-128]; ENSMUSG00000025194, Abcc2, ATP-binding cassette, sub-family C (CFTR/MRP), member 2, [Score=410, Expect=9e-122]} {Dmel: FBgn0032456, MRP, Multidrug-Resistance like Protein 1, [Score=424, Expect=9e-127]} {Celegans: WBGene00003408, mrp-2, Multidrug resistance related protein 2, [Score=395, Expect=1e-116]} {Smed: dd_Smed_v6_3982_0_1, dd_Smed_v6_3982_0_1, [Score=403, Expect=2e-119]} {RNA1509_17673} {RNA1310_13677} {RNA815_219} |
43. | MligTC455_36177 | 37 | 0.78 | Mlig455_012519 | Neo: - Age: Up-Down-Up |
FUK | 0.958 | - | - | - | - | 0.958 | - | Mlig455_012519 {REF} {Length: 3929} {TRANSSPLICED} {Pfam: GHMP kinases N terminal domain [PF00288.28, score=30.1]; L-fucokinase [PF07959.14, score=19.8]} {Human: ENSG00000157353, FUK, fucokinase, [Score=347, Expect=2e-105]} {Mouse: ENSMUSG00000033703, Fuk, fucokinase, [Score=316, Expect=3e-94]} {Celegans: WBGene00007745, C26D10.4, [RH, Score=171, Expect=3e-44]} {RNA1509_29540} {RNA1310_3161} {RNA815_21862} |
44. | MligTC455_49670 | 33 | 0.68 | Mlig455_047674 | Neo: Int S/G2/M Age: - Region-enriched R2: 4.520/0.04813 |
WSCD2 | 0.958 | - | - | - | 0.958 | - | - | Mlig455_047674 {REF} {Length: 875} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=52.8, Expect=9e-08]} {RNA1509_29094} {RNA1310_84271.1} {RNA815_51632} |
45. | MligTC455_50565 | 23 | 0.48 | Mlig455_059816 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_059816 {REF} {Length: 582} {NoTransDecoderORF} {RNA1509_13587} {RNA1310_94077} {RNA815_47403} | |
46. | MligTC455_07428 | 12 | 0.25 | Mlig455_055209 | Neo: - Age: - |
0.957 | - | - | 0.957 | - | - | - | Mlig455_055209 {REF} {Length: 759} {RNA1310_50531} {RNA815_29422} | |
47. | MligTC455_28416 | 134 | 2.78 | Mlig455_031360, Mlig455_056514 | Neo: - Age: - |
0.957 | - | - | 0.957 | - | - | - | Mlig455_031360 {REF} {Length: 267} {NoTransDecoderORF} {RNA1509_28242} {RNA1310_101668} {RNA815_48361} Mlig455_056514 {REF} {Length: 3270} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} |
|
48. | MligTC455_40850 | 7 | 0.14 | Mlig455_042076 | Neo: - Age: logFC(26M/2M)=0.689 |
0.957 | - | - | - | - | 0.957 | - | Mlig455_042076 {REF} {Length: 3408} {Pfam: REJ domain [PF02010.17, score=59.0]; PKD domain [PF18911.2, score=26.8]; PKD domain [PF00801.22, score=26.0]} {RNA1509_8046} {RNA1310_93} {RNA815_2228} | |
49. | MligTC455_50186 | 142 | 2.95 | Mlig455_069498 | Neo: - Age: logFC(26M/2M)=-0.479 |
CHRNA10 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_069498 {REF} {Length: 3405} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=107.1]; Immunoglobulin domain [PF13895.8, score=27.7]; Immunoglobulin domain [PF13927.8, score=25.7]; Immunoglobulin I-set domain [PF07679.18, score=25.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=110, Expect=5e-25]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-24]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=105, Expect=3e-23]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=105, Expect=3e-23]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=105, Expect=3e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=102, Expect=2e-22]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=100, Expect=1e-21]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=119, Expect=3e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=126, Expect=3e-30]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=105, Expect=1e-23]} {RNA1509_43700} {RNA1310_8429} {RNA815_11541} |
50. | MligTC455_53012 | 894 | 18.63 | Mlig455_029158, Mlig455_041436 | Neo: - Age: Down-Up-Down |
0.957 | - | - | - | - | 0.957 | - | Mlig455_029158 {REF} {Length: 848} {TRANSSPLICED} {RNA1509_24093} {RNA1310_59695} {RNA815_13022.1} Mlig455_041436 {REF} {Length: 1146} {TRANSSPLICED} {RNA1509_24093, RNA1509_34847} {RNA1310_59695, RNA1509_34847} {RNA1509_34847, RNA815_13022.1} |
|
51. | MligTC455_53475 | 1013 | 21.1 | Mlig455_057783 | Neo: - Age: - |
TLE4 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_057783 {REF} {Length: 3860} {Pfam: Groucho/TLE N-terminal Q-rich domain [PF03920.17, score=184.3]; WD domain, G-beta repeat [PF00400.34, score=68.0]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=43.7]} {Human: ENSG00000106829, TLE4, transducin like enhancer of split 4, [Score=566, Expect=0.0]; ENSG00000196781, TLE1, transducin like enhancer of split 1, [Score=566, Expect=0.0]; ENSG00000140332, TLE3, transducin like enhancer of split 3, [Score=563, Expect=0.0]; ENSG00000065717, TLE2, transducin like enhancer of split 2, [Score=547, Expect=0.0]} {Mouse: ENSMUSG00000034771, Tle2, transducin-like enhancer of split 2, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0001139, gro, groucho, [Score=570, Expect=0.0]} {Celegans: WBGene00006773, unc-37, Transcription factor unc-37, [Score=405, Expect=2e-131]} {Smed: dd_Smed_v6_4112_0_1, dd_Smed_v6_4112_0_1, [Score=665, Expect=0.0]} {RNA1509_4766} {RNA1310_6051} {RNA815_7108.1} |
52. | MligTC455_13207 | 41 | 0.86 | Mlig455_028002, Mlig455_028029 | Neo: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_028002 {REF} {Length: 2141} {RNA1310_77513} Mlig455_028029 {REF} {Length: 2600} {RNA1310_77513} |
|
53. | MligTC455_50049 | 291 | 6.06 | Mlig455_030763 | Neo: Germline Age: Up-Down-Down Region-specific R4: 5.826 Region-enriched R4: 3.092/0.00052 |
RAB12 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_030763 {REF} {Length: 1725} {Pfam: Ras family [PF00071.24, score=58.1]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=57.3]; 50S ribosome-binding GTPase [PF01926.25, score=21.3]; ADP-ribosylation factor family [PF00025.23, score=20.6]} {Human: ENSG00000206418, RAB12, RAB12, member RAS oncogene family, [Score=61.6, Expect=3e-10]; ENSG00000267261, AC099811.2, novel protein, [Score=59.7, Expect=8e-10]} {Mouse: ENSMUSG00000023460, Rab12, RAB12, member RAS oncogene family, [Score=59.3, Expect=8e-10]; ENSMUSG00000019173, Rab5c, RAB5C, member RAS oncogene family, [Score=57.0, Expect=3e-09]} {Dmel: FBgn0015797, Rab6, [Score=61.2, Expect=6e-11]} {Celegans: WBGene00004281, rab-28, RAB family, [Score=65.5, Expect=2e-12]} {Smed: dd_Smed_v6_3370_0_1, dd_Smed_v6_3370_0_1, [Score=70.1, Expect=3e-14]} {RNA1509_18190} {RNA1310_18285} {RNA815_6420} |
54. | MligTC455_15250 | 145 | 3.01 | Mlig455_066748 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_066748 {REF} {Length: 647} {NoTransDecoderORF} {RNA1509_52333, RNA1509_55685, RNA1509_56537} {RNA1310_27819, RNA1509_52333, RNA1509_55685} {RNA1509_52333, RNA1509_55685, RNA815_25553} | |
55. | MligTC455_47068 | 69 | 1.43 | Mlig455_060910 | Neo: - Age: - |
0.954 | - | - | 0.954 | - | - | - | Mlig455_060910 {REF} {Length: 1012} | |
56. | MligTC455_28656 | 562 | 11.7 | Mlig455_054734 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.388 Region-specific R4: 5.528 Region-enriched R4: 2.398/0.01738 |
SCNN1B | 0.953 | - | - | - | 0.953 | - | - | Mlig455_054734 {REF} {Length: 2972} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.6]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=54.7, Expect=2e-07]} {RNA1509_47645} {RNA1310_33504} {RNA815_9471.1} |
57. | MligTC455_12119 | 12 | 0.25 | Mlig455_060115 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_060115 {REF} {Length: 433} {NoTransDecoderORF} {RNA1509_32988} {RNA1310_83792} {RNA815_25791} | |
58. | MligTC455_39771 | 140 | 2.91 | Mlig455_016986 | Neo: - Age: - Region-enriched R7: 2.817/0.02272 |
GEM | 0.952 | - | - | - | - | 0.952 | - | Mlig455_016986 {REF} {Length: 2406} {Pfam: Ras family [PF00071.24, score=42.2]} {Human: ENSG00000164949, GEM, GTP binding protein overexpressed in skeletal muscle, [Score=70.1, Expect=2e-12]} {Mouse: ENSMUSG00000028214, Gem, GTP binding protein (gene overexpressed in skeletal muscle), [Score=70.1, Expect=9e-13]} {Dmel: FBgn0085419, Rgk2, Rad, Gem/Kir family member 2, [Score=120, Expect=2e-28]} {Celegans: WBGene00013124, Y52B11A.4, [Score=66.2, Expect=2e-11]} {Smed: dd_Smed_v6_11010_0_1, dd_Smed_v6_11010_0_1, [Score=127, Expect=8e-32]} {RNA1310_32533.2} {RNA815_17720} |
59. | MligTC455_07327 | 46 | 0.95 | Mlig455_001874, Mlig455_001949 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_001874 {REF} {Length: 1082} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.3]} {Celegans: WBGene00019444, frpr-11, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.4, Expect=3e-09]} {RNA1310_94087} {RNA815_48529} Mlig455_001949 {REF} {Length: 2058} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.4]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.0, Expect=4e-09]} {RNA1509_46461} {RNA1310_94087} {RNA815_57978} |
|
60. | MligTC455_17663 | 10 | 0.22 | Mlig455_052319 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_052319 {REF} {Length: 1808} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.9]} {Smed: dd_Smed_v6_54490_0_1, dd_Smed_v6_54490_0_1, [Score=44.3, Expect=8e-06]} {RNA1509_54447} {RNA1310_38734} {RNA815_28111} | |
61. | MligTC455_19719 | 160 | 3.32 | Mlig455_062741 | Neo: - Age: - |
ANKUB1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_062741 {REF} {Length: 2758} {Pfam: Ubiquitin family [PF00240.25, score=30.6]} {Human: ENSG00000206199, ANKUB1, ankyrin repeat and ubiquitin domain containing 1, [Score=268, Expect=2e-81]} {Mouse: ENSMUSG00000074591, Ankub1, ankrin repeat and ubiquitin domain containing 1, [Score=248, Expect=3e-74]} {Smed: dd_Smed_v6_9027_0_1, dd_Smed_v6_9027_0_1, [Score=470, Expect=8e-159]} {RNA1509_38601} {RNA1310_11316.1} {RNA815_657.1} |
62. | MligTC455_30572 | 88 | 1.82 | Mlig455_009374, Mlig455_026650 | Neo: - Age: Down-Down-Down |
NYNRIN | 0.951 | - | - | 0.951 | - | - | - | Mlig455_009374 {REF} {Length: 592} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.2} {RNA815_474.1} Mlig455_026650 {REF} {Length: 3906} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.3} {RNA815_474.1} |
63. | MligTC455_36066 | 190 | 3.96 | Mlig455_055150 | Neo: - Age: - |
0.951 | - | - | 0.951 | - | - | - | Mlig455_055150 {REF} {Length: 4368} {TRANSSPLICED} {RNA1509_38168} {RNA1310_732.1, RNA1509_38168} {RNA1509_38168, RNA815_9144} | |
64. | MligTC455_23129 | 58 | 1.21 | Mlig455_019471 | Neo: - Age: - Region-enriched R4: 3.358/0.03401 |
0.95 | - | - | 0.950 | - | - | - | Mlig455_019471 {REF} {Length: 1198} {Pfam: F5/8 type C domain [PF00754.27, score=36.6]; PAN domain [PF00024.28, score=22.7]} {RNA1310_33845.2} {RNA815_3664.1} | |
65. | MligTC455_23130 | 57 | 1.18 | Mlig455_066882 | Neo: - Age: - |
0.95 | - | - | 0.950 | - | - | - | Mlig455_066882 {REF} {Length: 1287} {Pfam: F5/8 type C domain [PF00754.27, score=36.4]; PAN domain [PF00024.28, score=21.3]} {RNA1310_33845.2} {RNA815_3664.1} | |
66. | MligTC455_28903 | 55 | 1.14 | Mlig455_030222, Mlig455_067999 | Neo: - Age: Up-Down-Down |
FAT4 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_030222 {REF} {Length: 8676} {Pfam: Cadherin domain [PF00028.19, score=744.0]; Cadherin-like [PF16184.7, score=94.9]; Cadherin-like [PF08266.14, score=40.7]; RET Cadherin like domain 1 [PF17756.3, score=23.4]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=518, Expect=1e-147]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=9e-152]} {Dmel: FBgn0001075, ft, fat, [Score=479, Expect=9e-136]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=260, Expect=4e-69]} {RNA1509_58830} {RNA1310_15141, RNA1509_58830} {RNA1509_58830, RNA815_18357} Mlig455_067999 {REF} {Length: 8147} {Pfam: Cadherin domain [PF00028.19, score=745.9]; Cadherin-like [PF16184.7, score=94.8]; Cadherin-like [PF08266.14, score=40.9]; RET Cadherin like domain 1 [PF17756.3, score=23.3]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=519, Expect=6e-148]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=7e-152]} {Dmel: FBgn0001075, ft, fat, [Score=476, Expect=8e-135]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=261, Expect=2e-69]} {RNA1509_58830} {RNA1310_15141} {RNA815_18357} |
67. | MligTC455_52941 | 123 | 2.57 | Mlig455_047636 | Neo: - Age: - Regeneration-upregulated BL: 5.109 Regeneration-enriched BL: 5.109 |
0.95 | - | - | 0.950 | - | - | - | Mlig455_047636 {REF} {Length: 729} {NoTransDecoderORF} {RNA1509_35506} {RNA1310_3152.3} {RNA815_54245} |